Précisez une action ou une cryptomonnaie dans la barre de recherche pour obtenir un récapitulatif
JB Chemicals & Pharmaceuticals Limited
JBCHEPHARMJ. B. Chemicals & Pharmaceuticals Limited manufactures and markets pharmaceutical formulations, herbal remedies, and active pharmaceutical ingredients (API) in India and internationally. The company's API product portfolio includes diclofenac sodium, diethylamine, acid, and potassium; nifedipine, atenolol, and cilnidipine; and ciprofloxacin, cetirizine, and meclizine HCI. It also provides dosage forms, such as tablets, lozenges, injectables, gels, creams, ointments, liquid herbal syrups, cold rubs, eye drops, troches, and capsules; and soft-centered, powder, medicated, and herbal lozenges, as well as various pharmaceutical dosage forms. In addition, it offers a range of contrast media products, including x-ray, magnetic resonance imaging (MRI), and ultrasound scanners; and contract manufacturing services. The company provides its products in gastroenterology, anti-infectives, wound care, neonatology and pediatrics, gynaecology, dental, vitamins and minerals, hypertension, diabetes, nephrology, respiratory, pain-analgesic, dermatology, antivirals, lozenges, and contrast media and radio diagnostic therapeutic areas. J. B. Chemicals & Pharmaceuticals Limited was incorporated in 1976 and is headquartered in Mumbai, India. Address: Cnergy IT Park, Mumbai, India, 400025
Analytics
Objectif de Cours de WallStreet
183 532.08 INRRatio C/B
43.8579Rendement du dividende
0.73 %Année actuelle
L'année dernière
Trimestre en cours
Le dernier trimestre
Année actuelle
L'année dernière
Trimestre en cours
Le dernier trimestre
Chiffres clés JBCHEPHARM
Analyse des dividendes JBCHEPHARM
Croissance des dividendes sur 5 ans
1712 %Croissance continue
1 annéeRatio de distribution Moyenne sur 5 ans
36 %Historique des dividendes JBCHEPHARM
Valorisation des titres JBCHEPHARM
financières JBCHEPHARM
Résultats | 2019 | Dynamique |